Filing Flows › Novo Nordisk A S (NVO) › Operating margin
Novo Nordisk A S (NVO) operating margin by quarter
Novo Nordisk A S' operating margin was 29.1% in Q3 2026 (third quarter 2026), -5.4 pts from Q2 2026. Over the last 6 quarters it ranged from 29.1% (Q3 2026) to 61.6% (Q1 2026).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 29.1% | -5.4 pts | -2.5 pts |
| Q2 2026 | 34.5% | -27.1 pts | -9.0 pts |
| Q1 2026 | 61.6% | +21.5 pts | — |
| Q4 2025 | 40.1% | +8.5 pts | — |
| Q3 2025 | 31.6% | -11.9 pts | — |
| Q2 2025 | 43.5% | — | — |
Q3 2026 at a glance
Novo Nordisk A S, Q3 2026: revenue $79.2B (+6% year over year), operating margin 29.1%, net earnings $16.7B, operating cash flow $41.7B. The chart follows the revenue to costs, profit and cash.
Questions
What is Novo Nordisk A S' operating margin?
Novo Nordisk A S' operating margin was 29.1% in Q3 2026 (third quarter 2026), -5.4 pts from Q2 2026.
How has Novo Nordisk A S' operating margin changed?
Over the last 6 quarters it ranged from 29.1% (Q3 2026) to 61.6% (Q1 2026).